EBV activates AMPK/mTOR/HIF1 pathway to promote glycolysis and induces angiogenesis in nasopharyngeal carcinoma cells (Zhang et al., 2017; Lyu et al., 2018). The gene discussed is HIF1A; the disease is nasopharyngeal carcinoma.